Skip to main content
Back
Watch Compare

TEVA PHARMACEUTICAL INDUSTRIES LTD

Data quality: 100%
TEVJF
NYSE Manufacturing Chemicals
$37.00
▲ $8.64 (30.47%)
Mkt Cap: 44.72 B
Price
$37.00
Mkt Cap
44.72 B
Day Range
$37.00 — $37.00
52-Week Range
$13.73 — $37.00
Volume
17
Open $37.00
50D / 200D Avg
$28.45
30.05% above
50D / 200D Avg
$22.45
64.85% above

Quick Summary

Key Takeaways

Revenue declined -44.56% annually over 5 years
ROE of 20.03% indicates high profitability
Net margin of 94.00% shows strong profitability
Generating 1.65 B in free cash flow
P/E of 31.71 — premium valuation
PEG of 0.89 suggests growth is underpriced

Growth

Revenue Growth (5Y)
-44.56%
Below sector avg (1.82%)
Revenue (1Y)-90.93%
Earnings (1Y)N/A
FCF Growth (3Y)9.79%

Quality

Return on Equity
20.03%
Above sector avg (-53.41%)
ROIC7.62%
Net Margin94.00%
Op. Margin143.80%

Safety

Debt / Equity
N/A
Current Ratio1.11
Interest Coverage2.35

Valuation

PE (TTM)
31.71
Above sector avg (-1.48)
P/B Ratio6.17
EV/EBITDA13.46
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E 31.7 -1.5
P/B 6.2 1.6
ROE % 20.0 -53.4
Net Margin % 94.0 -41.5
Rev Growth 5Y % -44.6 1.8
D/E — 0.3

ETFs Holding This Stock

MXIVX MXIVX
0.34% weight
MXJVX MXJVX
0.34% weight
MXECX MXECX
0.11% weight
MXEVX MXEVX
0.11% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -90.93% Revenue Growth (3Y) -69.23%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -44.56% Earnings Growth (5Y) 35.60%
Profitability
Revenue (TTM) 1.50 B Net Income (TTM) 1.41 B
ROE 20.03% ROA 3.53%
Gross Margin 595.87% Operating Margin 143.80%
Net Margin 94.00% Free Cash Flow (TTM) 1.65 B
ROIC 7.62% FCF Growth (3Y) 9.79%
Safety
Debt / Equity N/A Current Ratio 1.11
Interest Coverage 2.35 Asset Turnover 0.04
Working Capital 1.25 B Tangible Book Value -12.63 B
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 31.71 Forward P/E N/A
P/B Ratio 6.17 P/S Ratio 29.81
PEG Ratio 0.89 Forward PEG N/A
EV/EBITDA 13.46 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 3.69%
Market Cap 44.72 B Enterprise Value 42.51 B
Per Share
EPS (Diluted TTM) 1.21 Revenue / Share 1.24
FCF / Share 1.36 OCF / Share 1.36
EPS CAGR (1Y) N/A EPS CAGR (5Y) 33.58%
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 116.95%
SBC-Adj. FCF 1.51 B Growth Momentum -46.37

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.50 B 16.54 B 15.85 B 14.93 B 15.88 B
Net Income 1.41 B -1.64 B -559.00 M -2.35 B 417.00 M
EPS (Diluted) 1.21 -1.45 -0.50 -2.12 0.38
Gross Profit 8.94 B 8.06 B 7.65 B 6.97 B 7.59 B
Operating Income 2.16 B -303.00 M 433.00 M -2.10 B 1.72 B
EBITDA — — — — —
R&D Expenses — — — 98.00 M —
SG&A Expenses — — — — —
D&A 1.00 B 1.06 B 1.15 B 1.31 B 1.33 B
Interest Expense 916.00 M 1.00 B 1.03 B 930.00 M 891.00 M
Income Tax -180.00 M 676.00 M -7.00 M -638.00 M 211.00 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 40.75 B 39.33 B 43.48 B 44.01 B 47.67 B
Total Liabilities 32.83 B 33.61 B 35.35 B 35.32 B 36.42 B
Shareholders' Equity 7.91 B 5.37 B 7.51 B 7.90 B 10.28 B
Total Debt — — — — —
Cash & Equivalents 3.56 B 3.30 B 3.23 B 2.80 B 2.17 B
Current Assets 13.95 B 12.55 B 12.49 B 12.05 B 12.57 B
Current Liabilities 13.46 B 12.80 B 12.25 B 11.47 B 11.03 B